The COVID-19 pandemic and the use of MS disease-modifying therapies.

ABSTRACT:

SUBMITTER: Giovannoni G 

PROVIDER: S-EPMC7138156 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature